DeVinney Erick Wayne 4
4 · Axogen, Inc. · Filed Mar 19, 2025
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
DeVinney Erick Wayne
Chief Innovation Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-16+6,362→ 209,723 total - Exercise/Conversion
Common Stock
2025-03-16+23,150→ 232,873 total - Exercise/Conversion
Restricted Stock Units
2025-03-16−23,150→ 23,150 total→ Common Stock (23,150 underlying) - Exercise/Conversion
Common Stock
2025-03-16+2,950→ 203,361 total - Exercise/Conversion
Restricted Stock Units
2025-03-16−2,950→ 0 total→ Common Stock (2,950 underlying) - Sale
Common Stock
2025-03-19$17.50/sh−15,111$264,443→ 217,762 total - Exercise/Conversion
Restricted Stock Units
2025-03-16−6,362→ 6,363 total→ Common Stock (6,362 underlying)
Footnotes (7)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2025.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on March 16, 2025. This sale does not represent a discretionary trade by the Reporting Person.
- [F3]The reported price in Column 4 is a weighted average sale price. These shares were sold on March 19, 2025 in multiple transactions at $17.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F7]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.